drugset / Trial / NCT01415128

Compare the Pharmacokinetics of Omeprazole, Rosiglitazone, and Desipramine When Administered With Avanafil in Healthy Male Subjects

NCT01415128

Phase 1 Completed 60 enrolled VIVUS LLC
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This study will compare the pharmacokinetics of omeprazole, rosiglitazone and desipramine when administered with a single oral dose of avanafil in healthy male subjects.

Timeline

Start
2010-04
Primary completion
2010-05
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Desipramine Small molecule 50 mg Oral
Comparator Omeprazole Other / unclassified 40 mg Oral
Comparator Rosiglitazone Small molecule 8 mg Oral

Indications